Photo credit: www.sciencedaily.com
Breakthrough in TRPM8 Ion Channel Regulation Offers New Therapeutic Possibilities
Researchers at LMU have made a significant advancement in the regulation of an important ion channel, opening avenues for future therapeutic applications.
TRPM8 ion channels, located in the cell membrane, are well-known for their role as receptors that detect cold temperatures and respond to menthol, the active component in peppermint known for its cooling effects. Beyond sensory perception, these channels are implicated in pain modulation and various diseases, positioning them as essential targets for developing novel pharmaceuticals aimed at treating ailments such as cancer, metabolic disorders, and inflammatory conditions.
A dedicated research team at LMU, spearheaded by Professor Michael Mederos y Schnitzler from the Walther Straub Institute of Pharmacology and Toxicology, along with Dr. David B. Konrad, has collaborated with Professors Dirk Trauner from the University of Pennsylvania and Ursula Storch from the University of Regensburg to explore the intricate functions of TRPM8 channels. Their efforts have culminated in the creation of a groundbreaking molecule known as azo-menthol, which facilitates the precise regulation of TRPM8 channels through light exposure, as detailed in their publication in the journal Angewandte Chemie.
“For the first time, azo-menthol allows us to selectively activate TRPM8 channels with UV light and subsequently deactivate them using blue light, achieving spatiotemporal precision and reversibility,” states Mederos y Schnitzler. The utilization of light to manipulate biological mechanisms holds substantial promise for therapeutic interventions. Mederos y Schnitzler further remarks on the potential benefits of such photopharmacological strategies, particularly in avoiding systemic side effects commonly associated with traditional chemotherapy treatments. “The advancements in this field present exciting opportunities for innovative therapies that promise greater precision and reduced adverse effects,” he adds.
Source
www.sciencedaily.com